Company Information

CIN
Status
Date of Incorporation
18 December 2012
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2023
Last Annual Meeting
29 September 2023
Paid Up Capital
100,000
Authorised Capital
100,000

Directors

Radhika Khandelwal
Radhika Khandelwal
Director/Designated Partner
over 4 years ago
Deepak Khandelwal
Deepak Khandelwal
Director/Designated Partner
almost 13 years ago

Past Directors

Indra Jain
Indra Jain
Additional Director
over 10 years ago
Samyak Jain
Samyak Jain
Director
almost 13 years ago
Saurabh Jain
Saurabh Jain
Director
almost 13 years ago

Registered Trademarks

Rifocalm Actawin Lifesciences

[Class : 5] Medicinal & Pharmaceutical Preparations.

Df400 Actawin Lifesciences

[Class : 5] Medicinal & Pharmaceutical Preparations.

Documents

Form AOC-4-03042021_signed
Form MGT-7-01022021_signed
Form ADT-3-31122020
Directors report as per section 134(3)-31122020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-31122020
Resignation letter-31122020
List of share holders, debenture holders;-31122020
Form MGT-7-17012019_signed
Form AOC-4-07012019_signed
Form MGT-7-07012019_signed
List of share holders, debenture holders;-31122018
Directors report as per section 134(3)-31122018
Optional Attachment-(1)-31122018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-31122018
Form AOC-4-30032018_signed
Optional Attachment-(3)-29032018
Optional Attachment-(1)-29032018
List of share holders, debenture holders;-29032018
Directors report as per section 134(3)-29032018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-29032018
Optional Attachment-(2)-29032018
Form MGT-7-29032018_signed
Form AOC-4-29032018_signed
List of share holders, debenture holders;-27032018
Optional Attachment-(2)-28032017
Form DIR-12-28032017_signed
Optional Attachment-(1)-28032017
Form AOC-4-30012017_signed
Form MGT-7-30012017_signed
Directors report as per section 134(3)-28012017